BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 10893240)

  • 41. Different molecular sites of action for the KATP channel inhibitors, PNU-99963 and PNU-37883A.
    Cui Y; Tinker A; Clapp LH
    Br J Pharmacol; 2003 May; 139(1):122-8. PubMed ID: 12746230
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ATP modulation of ATP-sensitive potassium channel ATP sensitivity varies with the type of SUR subunit.
    Song DK; Ashcroft FM
    J Biol Chem; 2001 Mar; 276(10):7143-9. PubMed ID: 11115512
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of K(ATP)-channels in rat basilar and middle cerebral arteries: studies of vasomotor responses and mRNA expression.
    Jansen-Olesen I; Mortensen CH; El-Bariaki N; Ploug KB
    Eur J Pharmacol; 2005 Oct; 523(1-3):109-18. PubMed ID: 16226739
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Syntaxin-1A actions on sulfonylurea receptor 2A can block acidic pH-induced cardiac K(ATP) channel activation.
    Kang Y; Ng B; Leung YM; He Y; Xie H; Lodwick D; Norman RI; Tinker A; Tsushima RG; Gaisano HY
    J Biol Chem; 2006 Jul; 281(28):19019-28. PubMed ID: 16672225
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular characterization of a local sulfonylurea system in human adipose tissue.
    Gabrielsson BG; Karlsson AC; Lönn M; Olofsson LE; Johansson JM; Torgerson JS; Sjöström L; Carlsson B; Edén S; Carlsson LM
    Mol Cell Biochem; 2004 Mar; 258(1-2):65-71. PubMed ID: 15030171
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Physiological and pathophysiological roles of ATP-sensitive K+ channels.
    Seino S; Miki T
    Prog Biophys Mol Biol; 2003 Feb; 81(2):133-76. PubMed ID: 12565699
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hybrid assemblies of ATP-sensitive K+ channels determine their muscle-type-dependent biophysical and pharmacological properties.
    Tricarico D; Mele A; Lundquist AL; Desai RR; George AL; Conte Camerino D
    Proc Natl Acad Sci U S A; 2006 Jan; 103(4):1118-23. PubMed ID: 16418275
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interaction of the sulfonylthiourea HMR 1833 with sulfonylurea receptors and recombinant ATP-sensitive K(+) channels: comparison with glibenclamide.
    Russ U; Lange U; Löffler-Walz C; Hambrock A; Quast U
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1049-55. PubMed ID: 11714894
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A region of the sulfonylurea receptor critical for a modulation of ATP-sensitive K(+) channels by G-protein betagamma-subunits.
    Wada Y; Yamashita T; Imai K; Miura R; Takao K; Nishi M; Takeshima H; Asano T; Morishita R; Nishizawa K; Kokubun S; Nukada T
    EMBO J; 2000 Sep; 19(18):4915-25. PubMed ID: 10990455
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sulphonylurea receptor 2B and Kir6.1 form a sulphonylurea-sensitive but ATP-insensitive K+ channel.
    Yamada M; Isomoto S; Matsumoto S; Kondo C; Shindo T; Horio Y; Kurachi Y
    J Physiol; 1997 Mar; 499 ( Pt 3)(Pt 3):715-20. PubMed ID: 9130167
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Truncation of Kir6.2 produces ATP-sensitive K+ channels in the absence of the sulphonylurea receptor.
    Tucker SJ; Gribble FM; Zhao C; Trapp S; Ashcroft FM
    Nature; 1997 May; 387(6629):179-83. PubMed ID: 9144288
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Random assembly of SUR subunits in K(ATP) channel complexes.
    Cheng WW; Tong A; Flagg TP; Nichols CG
    Channels (Austin); 2008; 2(1):34-8. PubMed ID: 18690055
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of repaglinide on cloned beta cell, cardiac and smooth muscle types of ATP-sensitive potassium channels.
    Dabrowski M; Wahl P; Holmes WE; Ashcroft FM
    Diabetologia; 2001 Jun; 44(6):747-56. PubMed ID: 11440368
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential response of K(ATP) channels containing SUR2A or SUR2B subunits to nucleotides and pinacidil.
    Reimann F; Gribble FM; Ashcroft FM
    Mol Pharmacol; 2000 Dec; 58(6):1318-25. PubMed ID: 11093769
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A view of sur/KIR6.X, KATP channels.
    Babenko AP; Aguilar-Bryan L; Bryan J
    Annu Rev Physiol; 1998; 60():667-87. PubMed ID: 9558481
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ATP-sensitive K+ channels in pancreatic, cardiac, and vascular smooth muscle cells.
    Yokoshiki H; Sunagawa M; Seki T; Sperelakis N
    Am J Physiol; 1998 Jan; 274(1):C25-37. PubMed ID: 9458709
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human oocytes express ATP-sensitive K(+) channels.
    Du Q; Jovanović S; Sukhodub A; Barratt E; Drew E; Whalley KM; Kay V; McLaughlin M; Telfer EE; Barratt CL; Jovanović A
    Hum Reprod; 2010 Nov; 25(11):2774-82. PubMed ID: 20847183
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular aspects of ATP-sensitive K+ channels in the cardiovascular system and K+ channel openers.
    Fujita A; Kurachi Y
    Pharmacol Ther; 2000 Jan; 85(1):39-53. PubMed ID: 10674713
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Burst kinetics of co-expressed Kir6.2/SUR1 clones: comparison of recombinant with native ATP-sensitive K+ channel behavior.
    Alekseev AE; Kennedy ME; Navarro B; Terzic A
    J Membr Biol; 1997 Sep; 159(2):161-8. PubMed ID: 9307442
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmaco-topology of sulfonylurea receptors. Separate domains of the regulatory subunits of K(ATP) channel isoforms are required for selective interaction with K(+) channel openers.
    Babenko AP; Gonzalez G; Bryan J
    J Biol Chem; 2000 Jan; 275(2):717-20. PubMed ID: 10625598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.